UnknownNCT01858259

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Gabriela Riemekasten
Principal Investigator: Gabriela Riemekasten, Prof.
Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie
Enrollment: 1372 enrolled
Eligibility: All sexes
Timeline: 2013 – 2016

Study locations (11)

Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A & INSERM 1016, Paris, France
Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology, Bad Nauheim, Germany
Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Berlin, Germany
Centre for Pediatric Rheumatology, Klinikum Eilbek, Hamburg, Germany
Pecsi Tudomanyegyetem - University of Pecs, Pécs, Hungary
University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine, Florence, Italy
Policlinico, Via Pansini, Napoli-Italia, Italy
Felix-Platter Spital, University of Basel, Basel, Switzerland
University of Zurich, Department of Rheumatology, Zurich, Switzerland
The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital, Leeds, United Kingdom
Royal Free Hospital, University College London, London, United Kingdom

Collaborators

European Union · University of Giessen · University of Zurich · University of Paris 5 - Rene Descartes · University of Florence · University of Campania Luigi Vanvitelli · University of Basel · University College, London · Charite University, Berlin, Germany · University of Pecs · University of Leeds · Schoen Klinik Hamburg Eilbek

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01858259 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials